CVKD vs MNDY · $20.2M cap vs P/E 32, rev $1.23B
Cadrenal Therapeutics, Inc. Common Stock (CVKD) versus Monday.Com Ltd (MNDY) — a side-by-side from cached financials, not a winner call.
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is a biotechnology company listed on US.
Monday.Com Ltd (MNDY) is a software - application company listed on US.
CVKD does not have a complete income-statement cache yet.
Latest reported MNDY revenue for 2025-12-31 was $1.23B. Net income was $118.7M. Revenue was up 26.7% from 2024-12-31 to 2025-12-31. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
CVKD currently screens at market cap $20.2M. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
Not investment advice. Open the CVKD and MNDY stock pages for the full models.
Not investment advice.